Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05609045
What this trial is testing

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

Who this might be right for
COVID-19 Pandemic
Wuhan Rhegen Biotechnology Co., Ltd.
Not applicableUnknownNCT05468021
What this trial is testing

Puerto Rico COVID-19 Vaccine Uptake Study

Who this might be right for
COVID-19
University of Puerto Rico 394
Testing effectiveness (Phase 2)UnknownNCT05205083
What this trial is testing

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 480
Post-approval studies (Phase 4)Study completedNCT05499351
What this trial is testing

Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine

Who this might be right for
COVID-19
Sinovac Biotech Co., Ltd 3,000
Post-approval studies (Phase 4)Study completedNCT05142319
What this trial is testing

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

Who this might be right for
COVID-19
Tan Tock Seng Hospital 326
Not applicableStudy completedNCT05529030
What this trial is testing

COVID-19 Booster Readiness Survey

Who this might be right for
Vaccination Refusal
Geisinger Clinic 12,036
Early research (Phase 1)Study completedNCT05181709
What this trial is testing

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

Who this might be right for
SARS-CoV-2
Sean Liu 35
Large-scale testing (Phase 3)UnknownNCT05124171
What this trial is testing

Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination

Who this might be right for
COVID-19Vaccine Reaction
Assistance Publique - Hôpitaux de Paris 247
Very early researchUnknownNCT05928468
What this trial is testing

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 210
Large-scale testing (Phase 3)UnknownNCT05602558
What this trial is testing

The Phase Ⅱ/Ⅲ Trial of LYB001

Who this might be right for
COVID-19
Yantai Patronus Biotech Co., Ltd. 18,000
Testing effectiveness (Phase 2)Study completedNCT05198102
What this trial is testing

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

Who this might be right for
Prevention of COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT05463354
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 410
Not applicableStudy completedNCT05283902
What this trial is testing

Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine-Preventable Diseases
Federal University of Espirito Santo 260
Early research (Phase 1)Study completedNCT04568811
What this trial is testing

The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine

Who this might be right for
Adenovirus Type-5 Vectored COVID-19 Vaccine
Jiangsu Province Centers for Disease Control and Prevention 89
Early research (Phase 1)Study completedNCT05050474
What this trial is testing

Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

Who this might be right for
COVID19
Livzon Pharmaceutical Group Inc. 43
Not applicableStudy completedNCT05104359
What this trial is testing

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Who this might be right for
COVID-19COVID-19 VaccinesImmunogenicity, Vaccine
Epividian 825
Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Large-scale testing (Phase 3)UnknownNCT05911061
What this trial is testing

A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 4,950
Post-approval studies (Phase 4)Study completedNCT05057169
What this trial is testing

Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)

Who this might be right for
COVID-19 Vaccination
The University of Hong Kong 451
Post-approval studies (Phase 4)Active Not RecruitingNCT07051031
What this trial is testing

COVID-19 Reactogenicity

Who this might be right for
COVID-19
Marcel Curlin 1,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation